Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > New Press Release - Sernova Corp. Announces Change of Auditor

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Oct 24, 2022 12:17pm

148 Views

Post# 35043957

RE:RE:New Press Release - Sernova Corp. Announces Change of Auditor

LOL.

Oh Rixy, they are in the big leagues alright. Big leagues of expensive auditors. Sernova needs to make money before you can worry about creative accounting. Unless they are legally required to disclose in a separate NR, this is just a make work project for the million dollar IR company. They are really earning their keep!

rixpix wrote: By Hiring KPMG, SVA is now in the big leagues.

Creative accounting is a thing.
2+2 = anything you want it to be.

Take from it what you want.

All IMHO!